Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Nu-Med Plus (NUMD) Change in Accured Expenses (2016 - 2025)

Nu-Med Plus' Change in Accured Expenses history spans 10 years, with the latest figure at $21493.0 for Q4 2021.

  • On a quarterly basis, Change in Accured Expenses rose 24.62% to $21493.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $66536.0, a 116.37% increase, with the full-year FY2025 number at $3290.0, down 62.27% from a year prior.
  • Change in Accured Expenses hit $21493.0 in Q4 2021 for Nu-Med Plus, up from $15020.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for NUMD hit a ceiling of $21493.0 in Q4 2021 and a floor of -$10511.0 in Q3 2018.
  • Historically, Change in Accured Expenses has averaged $5501.7 across 5 years, with a median of $4110.0 in 2017.
  • Biggest five-year swings in Change in Accured Expenses: tumbled 355.74% in 2018 and later soared 670.71% in 2020.
  • Tracing NUMD's Change in Accured Expenses over 5 years: stood at $3846.0 in 2017, then tumbled by 373.3% to -$10511.0 in 2018, then surged by 71.25% to -$3022.0 in 2019, then soared by 670.71% to $17247.0 in 2020, then grew by 24.62% to $21493.0 in 2021.
  • Business Quant data shows Change in Accured Expenses for NUMD at $21493.0 in Q4 2021, $15020.0 in Q3 2021, and $15001.0 in Q2 2021.